Epstein–Barr Virus (EBV) contributes to the development of lymphoid and epithelial
malignancies. While EBV's latent phase is more commonly associated with EBV-associated …

Epstein-Barr virus (EBV) is a member of the human herpesvirus family and, like many other
herpesviruses, maintains a lifelong latent association with B lymphocytes and a permissive …

The two Epstein-Barr virus (EBV) types, EBV-1 and EBV-2, are known to differ in their EBNA-
2 genes, which are 64 and 53% identical in their nucleotide and predicted amino acid …

The Jijoye EBV strain is characterized by a substitution of 1.8 kb in the C-terminal part of the
EBNA 2 gene compared to B95-8 or M-ABA virus. This made it possible to construct …

We have investigated the in vivo safety, efficacy, and persistence of autologous Epstein Barr
virus (EBV)–specific cytotoxic T lymphocytes (CTLs) for the treatment of solid organ …

Epstein-Barr virus (EBV) infects and activates resting human B lymphocytes, reprograms
them, induces their proliferation, and establishes a latent infection in them. In established …

Summary All Epstein-Barr virus (EBV) isolates can be classified as type A or type B
depending upon the identity of their EBV nuclear antigen (EBNA) 2 protein. The great …

Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …

Since the discovery of Epstein-Barr virus (EBV) from a cultured Burkitt's lymphoma cell line
in 1964, the virus has been associated with Burkitt's lymphoma, nasopharyngeal carcinoma …

The P3J-HR-1 strain of Epstein-Barr virus (EBV) fails to immortalize human lymphocytes. We
wished to understand the nature of the genomic alterations which correlated with the loss of …